Adjuvant Therapy of Melanoma With Sentinel Node Micrometastasis: Anti-PD-1 Render Superior RFS vs. Ipi, Dabrafenib / Trametinib in Stage 3 V600E/K BRAF Disease Have Survival Advantage

November 28, 2019

0 Comments
Login to view comments. Click here to Login